{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:47:04Z","timestamp":1786996024125,"version":"build-2736575974"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.pupt.2016.09.007","type":"journal-article","created":{"date-parts":[[2016,9,18]],"date-time":"2016-09-18T09:16:11Z","timestamp":1474190171000},"page":"48-51","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Erdosteine reduces the exercise-induced oxidative stress in patients with severe COPD: Results of a placebo-controlled trial"],"prefix":"10.1016","volume":"41","author":[{"given":"Roberto W.","family":"Dal Negro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Visconti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2016.09.007_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1378\/chest.10-1252","article-title":"Systemic manifestations of COPD","volume":"139","author":"Nussbaumer-Ochsner","year":"2011","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2016.09.007_bib2","series-title":"Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD)","year":"2016"},{"key":"10.1016\/j.pupt.2016.09.007_bib3","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1513\/pats.200701-004FM","article-title":"Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should)","volume":"4","author":"Agust\u00ed","year":"2007","journal-title":"Proc. Am. Thorac. Soc."},{"key":"10.1016\/j.pupt.2016.09.007_bib4","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1183\/09031936.03.00405703","article-title":"Systemic effects of chronic obstructive pulmonary disease","volume":"21","author":"Agust\u00ed","year":"2003","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2016.09.007_bib5","series-title":"COPD Fact Sheet","author":"World Health Organization","year":"2016"},{"key":"10.1016\/j.pupt.2016.09.007_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1378\/chest.08-2114","article-title":"Risk of COPD from exposure to biomass smoke: a metaanalysis","volume":"138","author":"Hu","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.pupt.2016.09.007_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2174\/1389450111314020007","article-title":"Antioxidants and mucolytics in COPD management: when (if ever) and in whom?","volume":"14","author":"Hillas","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.pupt.2016.09.007_bib8","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.rmed.2005.09.014","article-title":"Future perspectives in COPD","volume":"99","author":"Celli","year":"2005","journal-title":"Respir. Med."},{"key":"10.1016\/j.pupt.2016.09.007_bib9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1183\/09031936.02.00014302","article-title":"Evidence of local exercise-induced systemic oxidative stress in chronic obstructive pulmonary disease patients","volume":"20","author":"Couillard","year":"2002","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.pupt.2016.09.007_bib10","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1164\/rccm.200209-1028OC","article-title":"Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease","volume":"167","author":"Couillard","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.09.007_bib11","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.2147\/COPD.S87091","article-title":"Erdosteine reduces inflammation and time to first exacerbation postdischarge in hospitalized patients with AECOPD","volume":"10","author":"Moretti","year":"2015","journal-title":"Int. J. Chronic Obstr. Pulm. Dis."},{"key":"10.1016\/j.pupt.2016.09.007_bib12","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pupt.2015.06.004","article-title":"Efficacy of erdosteine 900 versus 600 mg\/day in reducing oxidative stress in patients with COPD exacerbations: results of a double blind, placebo-controlled trial","volume":"33","author":"Dal Negro","year":"2015","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2016.09.007_bib13","first-page":"111","article-title":"ATS statement: guidelines for the six-minute walk test. ATS committee on proficiency standards for clinical pulmonary function laboratories","volume":"2002 166","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.09.007_bib14","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.pupt.2007.07.004","article-title":"Changes in blood ROS, e-NO and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD","volume":"21","author":"Dal Negro","year":"2008","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2016.09.007_bib15","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1164\/rccm.200811-1757ST","article-title":"Committee on nonsmoking COPD, environmental and occupational health assembly. an official American thoracic society public policy statement: novel risk factors and the global burden of chronic obstructive pulmonary disease","volume":"182","author":"Eisner","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.09.007_bib16","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1586\/ecp.12.16","article-title":"Strategies to decrease ongoing oxidant burden in chronic obstructive pulmonary disease","volume":"5","author":"Rahman","year":"2012","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.pupt.2016.09.007_bib17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1096\/fj.01-0409fje","article-title":"Loss in oxidative stress tolerance with aging linked to reduced extracellular signal-regulated kinase and Akt kinase activities","volume":"16","author":"Ikeyama","year":"2002","journal-title":"FASEB J."},{"key":"10.1016\/j.pupt.2016.09.007_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1055\/s-2000-8881","article-title":"Physical activity and oxidative stress during aging","volume":"21","author":"Polidori","year":"2000","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.pupt.2016.09.007_bib19","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1164\/ajrccm.153.3.8630582","article-title":"Peripheral muscle weakness contributes to exercise limitation in COPD","volume":"153","author":"Gosselink","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.09.007_bib20","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1164\/ajrccm.152.6.8520771","article-title":"Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders","volume":"152","author":"Hamilton","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.09.007_bib21","doi-asserted-by":"crossref","first-page":"972","DOI":"10.3906\/sag-1308-65","article-title":"Association analyses of oxidative stress, aerobic capacity, daily physical activity, and body composition parameters in patients with mild to moderate COPD","volume":"44","author":"Gen\u00e7","year":"2014","journal-title":"Turk. J. Med. Sci."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553916301018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553916301018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,13]],"date-time":"2019-09-13T14:05:58Z","timestamp":1568383558000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553916301018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":21,"alternative-id":["S1094553916301018"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2016.09.007","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erdosteine reduces the exercise-induced oxidative stress in patients with severe COPD: Results of a placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2016.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}